IMAX (NYSE:IMAX) Stock Price Expected to Rise, Benchmark Analyst Says

IMAX (NYSE:IMAX) had its target price boosted by equities researchers at Benchmark from $42.00 to $44.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Benchmark’s target price would suggest a potential upside of 2.66% from the stock’s current price.

Other research analysts also recently issued research reports about the stock. Barrington Research reiterated an “outperform” rating and issued a $42.00 price objective on shares of IMAX in a research report on Monday, January 26th. Weiss Ratings reissued a “buy (b)” rating on shares of IMAX in a research report on Monday, December 29th. The Goldman Sachs Group raised IMAX from a “sell” rating to a “neutral” rating and raised their price target for the stock from $22.00 to $34.00 in a report on Tuesday, November 25th. Wells Fargo & Company increased their price target on IMAX from $40.00 to $47.00 and gave the stock an “overweight” rating in a report on Thursday, December 18th. Finally, Macquarie Infrastructure upped their price objective on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a report on Thursday, January 15th. Ten research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $43.00.

IMAX Stock Performance

Shares of IMAX opened at $42.86 on Thursday. IMAX has a fifty-two week low of $20.48 and a fifty-two week high of $43.16. The company has a 50 day moving average price of $36.44 and a 200-day moving average price of $33.99. The stock has a market capitalization of $2.31 billion, a PE ratio of 69.13, a PEG ratio of 2.07 and a beta of 0.38.

IMAX (NYSE:IMAX) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.15. IMAX had a return on equity of 13.69% and a net margin of 8.50%.The company had revenue of $125.21 million during the quarter, compared to analysts’ expectations of $120.30 million. During the same period last year, the business posted $0.27 earnings per share. The firm’s revenue was up 35.1% compared to the same quarter last year. Equities research analysts forecast that IMAX will post 0.91 EPS for the current year.

Institutional Trading of IMAX

A number of large investors have recently modified their holdings of the company. JPMorgan Chase & Co. grew its holdings in IMAX by 10.9% during the second quarter. JPMorgan Chase & Co. now owns 1,029,602 shares of the company’s stock worth $28,788,000 after acquiring an additional 101,048 shares during the period. Principal Financial Group Inc. raised its holdings in shares of IMAX by 67.8% during the third quarter. Principal Financial Group Inc. now owns 70,927 shares of the company’s stock worth $2,323,000 after acquiring an additional 28,667 shares in the last quarter. Zhang Financial LLC purchased a new position in IMAX in the third quarter valued at about $903,000. Emerald Mutual Fund Advisers Trust acquired a new position in IMAX in the 3rd quarter worth about $4,893,000. Finally, Thrivent Financial for Lutherans acquired a new position in IMAX in the 3rd quarter worth about $3,272,000. Institutional investors and hedge funds own 93.51% of the company’s stock.

IMAX News Roundup

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Q4 earnings beat and strong growth — IMAX reported $0.58 EPS vs. $0.43 consensus and revenue of $125.2M (up ~35% y/y), driven by blockbuster titles and higher profitability. This is the primary catalyst for the stock move. Earnings Report
• Positive Sentiment: Analyst upgrades — JPMorgan raised its price target to $48 and kept an “overweight” rating, signaling meaningful upside; Benchmark also raised its target to $44 and reiterated a “buy”. Analyst bullishness supports further upside sentiment. Analyst Note Benchmark Note
• Positive Sentiment: Strong box-office backdrop and targets — Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach, suggesting recurring upside if tentpoles and slate perform. Box Office Target
• Positive Sentiment: Content wins and programming diversification — Dune 3 secured exclusive IMAX opening-weekend play in select markets (good for premium ticket sales), Studio Ghibli re-releases and live F1 broadcasts broaden non-traditional revenue streams. Dune 3 Article Ghibli Re-release F1 in IMAX
• Neutral Sentiment: Institutional support — Rosenblatt reiterated a buy and other boutiques remain constructive; this helps sentiment but is not new fundamental strength. Rosenblatt Note
• Neutral Sentiment: Investor materials available — The earnings call transcript and slide deck were published for deeper inspection; useful for gauging guidance and margin drivers but not an immediate price catalyst. Earnings Call Transcript
• Negative Sentiment: Opening-weekend windowing risk — Major title Avengers: Doomsday will not have an IMAX opening-weekend release in the U.S., which could blunt upside from that particular tentpole and offset some gains from other exclusives. Avengers Windowing

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.